Loading, please wait...
This program aims for learners to competently understand and utilize information pertaining to rapid sequence induction and intubation and etomidate.
Fee
$10.00
CE Hours
1.00
CE Units
0.100
Activity Type
- Knowledge
Target Audience(s)
- Pharmacists
Accreditation(s)
|
Shenandoah University Bernard J. Dunn School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
Requirements for CE Credit
To receive credit the following items must be completed
1. Register for the event through supharmacy.learningexpressce.com
2. Attend the entire activity
3. Complete all relevant learning assessments
4. Complete an activity evaluation through supharmacy.learningexpressce.com
Support/Credits
No external funding has been obtained for this activity. The speakers have no conflicts of interest to disclose.
Objectives
- List the sequence of events that occur for successful Rapid Sequence Induction (RSI)
- Describe the indication of various agents used in RSI as well as the mechanism of action, dosing and administration, contraindications, adverse events, and monitoring parameters
- Review current literature and assess the data supporting etomidate's use as an induction agent
- Discuss the adverse events associated with etomidate's use such as adrenal insufficiency and mortality
- Evaluate which agents are clinically most appropriate to use based on patient and agent factors to assist during an RSI event
Speaker(s)/Author(s)
|
Favour Eluma
Brief Bio : Dr. Favour Eluma, PharmD is the current PGY-1 pharmacy resident for UVA Prince William Medical Center. She is a 2021 graduate from the University of Maryland School of Pharmacy. Her professional interests lies in internal medicine and infectious disease. |
Activity Number
0101-0000-22-001-H01-P
Release Date:
Feb 15, 2022
Credit Expiration Date:
Feb 15, 2025
CE Hours
1.00
Fee
$10.00